FDA NDC Directory · JSON-LD · Markdown

Theophylline

NDC 0480-3310 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA216961
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE (300 mg/1)
Marketing started20230127
Package count1

External sources

Source: openFDA. Public-domain (CC0).